CIFOBAN 136mmol / l infusion solution medication leaflet

B05ZB sodium citrate • Blood and blood forming organs | Hemodialytics and hemofiltrates | Hemofiltrates

Sodium citrate is a compound used in medicine as a urinary alkalinizer, anticoagulant, and corrector of electrolyte imbalances. It works by increasing urine pH, preventing kidney stone formation, and reducing urinary tract irritation.

The medication is administered orally or intravenously, as directed by a doctor, depending on the condition being treated. It is important for patients to follow the prescribed dosage and undergo regular check-ups to monitor electrolyte balance.

Patients should be aware of potential side effects, such as nausea, diarrhea, or abdominal discomfort. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, diarrhea, and abdominal discomfort. In rare cases, severe reactions such as hypernatremia or metabolic alkalosis may occur. Patients should be informed of these risks before starting treatment.

General data about CIFOBAN 136mmol / l

Substance: sodium citrate

Commercial code: W68772001

Concentration: 136mmol / l

Pharmaceutical form: infusion solution

Product type: generic

Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.

Marketing authorisation

Manufacturer: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH - GERMANIA

Holder: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH - GERMANIA

Number: 14396/2022/01

Shelf life: 2 years-after packaging for sale; after the first opening a pungii-it is used immediately